Egetis Therapeutics AB (publ) (STO:EGTX)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Aladote	100.00K	-	-	-	-
Emcitate	62.30M	46.10M	57.60M	21.90M	15.70M
Emcitate Growth	35.14%	-19.97%	163.01%	39.49%	809.09%
Common	-	-	-	600.00K	-
PledOx	-	-	-	-	22.60M
PledOx Growth	-	-	-	-	-41.95%
Total	62.40M	46.10M	57.60M	22.50M	38.30M
Total Growth	35.36%	-19.97%	156.00%	-41.25%	-5.81%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Europe (excluding Sweden)	61.50M	44.10M	-	-	-
Europe (excluding Sweden) Growth	39.46%	-	-	-	-
Sweden	500.00K	500.00K	1.30M	1.90M	1.30M
Sweden Growth	0%	-61.54%	-31.58%	46.15%	1466.27%
Rest of the World	400.00K	1.50M	4.70M	3.00M	2.50M
Rest of the World Growth	-73.33%	-68.09%	56.67%	20.00%	186.70%
Japan	-	-	14.50M	600.00K	22.60M
Japan Growth	-	-	2316.67%	-97.35%	-41.95%
France	-	-	5.80M	3.90M	2.90M
France Growth	-	-	48.72%	34.48%	786.85%
Spain	-	-	5.00M	3.40M	2.90M
Spain Growth	-	-	47.06%	17.24%	962.27%
Great Britain	-	-	2.40M	2.50M	2.80M
Great Britain Growth	-	-	-4.00%	-10.71%	1527.91%
Italy	-	-	2.00M	2.20M	1.00M
Italy Growth	-	-	-9.09%	120.00%	-
Poland	-	-	2.60M	1.70M	700.00K
Poland Growth	-	-	52.94%	142.86%	-
Australia	-	-	2.50M	1.90M	1.40M
Australia Growth	-	-	31.58%	35.71%	-
Germany	-	-	16.90M	1.60M	-
Germany Growth	-	-	956.25%	-	-
Total	62.40M	46.10M	57.70M	22.70M	38.10M
Total Growth	35.36%	-20.10%	154.19%	-40.42%	-6.30%

Source: S&P Global Market Intelligence.